계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Novel Therapeutic Technologies
company
About
Novel Therapeutic Technology develops practical drug delivery systems.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $75M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2003
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Novel Therapeutic Technology Inc. (NTT) is a leading pioneer in the development of sophisticated and practical drug delivery systems. NTT’s Ethosome technology provides the means to significantly enhance drug penetration of topical delivery applications, exponentially increasing therapeutic efficiency. With worldwide recognized drugs combined with NTT know-how, Pharmaceutical companies are able to introduce new and better drugs to the market, thus greatly reducing side effects, improving patient compliance, and increasing the patient's quality of life.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$75M
Novel Therapeutic Technologies has raised a total of
$75M
in funding over 2 rounds. Their latest funding was raised on
Dec 19, 2011 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 19, 2011 | Series Unknown | $75M | 1 |
Access BridgeGap Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Novel Therapeutic Technologies is funded by 1 investors.
Access BridgeGap Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Access BridgeGap Ventures
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
